innovation for industry
Articles ＆ files | Files | Infrastructures | Health ＆ life sciences | Nanomedicine | Nanosciences
The 5,500 sq. m nano-biotechnology platform deploys a full range of medical systems development know-how from sample surface preparation, biological analysis and substrate functionalization to packaging, microfluidics, microsystems, biological detection systems and component readers.
The nano-biotechnology platform covers a surface area of 5500 m² and groups all the skills needed to develop higher-efficiency, less invasive medical devices with low energy consumption.
The nano-biotechnology platform covers various types of system in a One Health approach, which considers people in their environment and in their life course. These systems are organized around 4 focus areas, ranging from in vitro diagnostic devices to wearable healthcare devices, via tools for pharma and bioproduction and tools for the environment and the exposome. The platform calls upon a variety of leading-edge technologies: imagery and non-conventional optical devices, innovative therapy devices, nano-medicine and vaccination, biomaterials, electronic and electrochemical sensors, labs on a chip, organoids on a chip, AI and embedded artificial intelligence.
This platform contains several installations:
PARTNERS:Thirty or so industrial partners, including Fluoptics, Horiba, Diabeloop and Lallemand.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.